Cargando…

Comparison of Different Furosemide Regimens in the Treatment of Acute Heart Failure: A Meta-Analysis

BACKGROUND: To compare the effects of different dosing schemes of furosemide on acute heart failure (AHF). METHODS: Literature that compared the efficacy of continuous and intermittent administration of furosemide in AHF patients was retrieved from PubMed, Embase, the Cochrane Library, and ISI Web o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Youpan, Guo, Feijie, Chen, Daori, Lin, Haiman, Huang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410848/ https://www.ncbi.nlm.nih.gov/pubmed/36035285 http://dx.doi.org/10.1155/2022/4627826

Ejemplares similares

‘Door-to-furosemide’ timing: early treatment of heart failure
por: Piazza, Vito
Publicado: (2019)

Comparison of continuous infusion and intermittent boluses of furosemide in acute heart failure: A protocol for systematic review and meta-analysis
por: Wang, Tao, et al.
Publicado: (2021)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
por: Ng, Tien M.H., et al.
Publicado: (2020)

Effect of Hypertonic Saline Solution Combined with Furosemide on Acute Heart Failure: A Meta-Analysis
por: Li, Zuoqing, et al.
Publicado: (2022)

Proteomic differences among patients with heart failure taking furosemide or torsemide
por: Cooper, Lauren B., et al.
Publicado: (2022)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Association of early administration of furosemide with improved oxygenation in patients with acute heart failure
por: Mikami, Takafumi, et al.
Publicado: (2021)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis
por: Lee, Tao Han, et al.
Publicado: (2021)

Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure
por: Jujo, Kentaro, et al.
Publicado: (2016)

Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study
por: Rahhal, Alaa, et al.
Publicado: (2019)

Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF
por: Ouwerkerk, Wouter, et al.
Publicado: (2022)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
por: Ahmed, Fozia Z., et al.
Publicado: (2021)

Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation
por: van der Vorst, Maria MJ, et al.
Publicado: (2006)

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
por: Herrera-Leaño, Nancy, et al.
Publicado: (2023)

Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men
por: Rasmussen, Tyler P., et al.
Publicado: (2019)

Dose of furosemide before admission predicts diuretic efficiency and long‐term prognosis in acute heart failure
por: Blázquez‐Bermejo, Zorba, et al.
Publicado: (2021)

Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients
por: CHEN, ZHI-HAO, et al.
Publicado: (2016)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution
por: Sica, Domenic A., et al.
Publicado: (2018)

A Pharmacogenetic Investigation of Intravenous Furosemide in Decompensated Heart Failure: A Meta-Analysis of 3 Clinical Trials
por: de Denus, Simon, et al.
Publicado: (2016)

A new paradigm for the treatment of volume overload in heart failure-combined effect of tolvaptan with furosemide
por: Okamoto, Hiroshi
Publicado: (2013)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Machine learning-based prognostic modeling of patients with acute heart failure receiving furosemide in intensive care units
por: Kamio, Tadashi, et al.
Publicado: (2023)

The added value of hypertonic saline solution to furosemide monotherapy in patients with acute decompensated heart failure: A meta‐analysis and trial sequential analysis
por: Diaz‐Arocutipa, Carlos, et al.
Publicado: (2023)

Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction: A protocol for systematic review and meta-analysis
por: Chen, Siqi, et al.
Publicado: (2021)

Albumin and furosemide for acute lung injury
por: Khan, Asjad, et al.
Publicado: (2007)

Effectiveness of inhaled furosemide for acute asthma exacerbation: a meta-analysis
por: Inokuchi, Ryota, et al.
Publicado: (2014)

Effects of intravenous furosemide plus small‐volume hypertonic saline solutions on markers of heart failure
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction
por: Zheng, Zhigui, et al.
Publicado: (2021)

Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection
por: Sager, Rana, et al.
Publicado: (2020)

Comparative effectiveness of furosemide vs torasemide in symptomatic therapy in heart failure patients: A randomized controlled study protocol
por: Li, Yifan, et al.
Publicado: (2021)

Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial
por: Gao, Yibing, et al.
Publicado: (2021)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

An exploratory study with an adaptive continuous intravenous furosemide regimen in neonates treated with extracorporeal membrane oxygenation
por: van der Vorst, Maria MJ, et al.
Publicado: (2007)

Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure
por: Loughran, Kerry A., et al.
Publicado: (2020)

Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose–Response Curves in Worsening Refractory Congestive Heart Failure
por: Paterna, Salvatore, et al.
Publicado: (2015)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
por: Ibrahim, Ayman, et al.
Publicado: (2020)

The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure
por: Shi, Jinzheng, et al.
Publicado: (2022)

Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study
por: Civera, Jose, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i1ohq05jbcvft1guojpsgsrq5n